Immediate Impact
45 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Digestive cancers: mechanisms, therapeutics and management
2025 Standout
Works of Filippo Pelizzaro being referenced
Circulating MicroRNA-21 and MicroRNA-122 as Prognostic Biomarkers in Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization
2021
Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Filippo Pelizzaro | 197 | 169 | 87 | 37 | 374 | |
| K Tanikawa | 180 | 120 | 68 | 21 | 362 | |
| Naruhiro Kimura | 88 | 100 | 112 | 43 | 401 | |
| A Blanchi | 165 | 112 | 134 | 22 | 383 | |
| Yuki Tsuji | 144 | 189 | 118 | 43 | 419 | |
| Junichi Tazawa | 245 | 196 | 138 | 29 | 445 | |
| Satoshi Itano | 213 | 154 | 154 | 52 | 419 | |
| Mohammed Elhendawy | 186 | 146 | 132 | 20 | 438 | |
| Satoshi Tsunematsu | 191 | 188 | 52 | 35 | 428 | |
| Lucia Cerrito | 238 | 157 | 98 | 38 | 449 | |
| C.A.F. Escanhoela | 139 | 128 | 140 | 41 | 346 |
All Works
Login with ORCID to disown or claim papers
Loading papers...